Idogen is investigating reverse acquisitions to avoid risk of liquidation
Idogen's work on capitalization has not yet achieved the required result. Idogen is now evaluating, among other things, the possibility of a reverse acquisition. If capital is not added to the company, the board will propose a liquidation. ”Idogen announced in a press release on April 3 that the funds will last until the end of June. The work on this year's capitalization has not yet obtained the required result. Idogen is now investigating, among other things, the possibilities for a reverse acquisition (i.e. another company takes over Idogen's listing at the stock market through